SLC2A1 and CA2 were highly expressed, and CUX1 was weakly expressed, in cervical cancer tissues, as determined by immunohistochemistry (Figure 9(A,C,E)) and RT-qPCR (Figure 9(B,D,F)). This evidence concerns the gene SLC2A1 and cervical carcinoma.